TOKYO - Monday, September 29th 2014 [ME NewsWire]

(BUSINESS WIRE)--Toshiba Corporation (TOKYO: 6502) today announced that the company has concluded a memorandum of understanding (MOU) with Ethiopian Electric Power on a comprehensive partnership in geothermal power that will see the parties collaborate in power generation projects and personnel development.

Ethiopian Electric Power (EEP), a publicly owned utility, engages in the development of geothermal resources and the construction of power plants. Through the partnership with EEP, Toshiba will draw on its long-standing experience and expertise in geothermal systems to contribute to projects in Ethiopia. More specifically, the company will develop and manufacture major equipment, create operation and management guidelines, cooperate in personnel development, and start a waste heat utilization business.

Ethiopia is geothermal rich, with resources estimated at equivalent to 6,000 megawatts. However, this pote ... Read more »

Company unveils three flagship smartphones Grand SII LTE, Nubia Z5S Mini and Blade Vec 4G at Gitex Shopper Autumn 2014

DUBAI, UAE - Monday, September 29th 2014 [ME NewsWire]

Gitex Shopper Autumn 2014

(BUSINESS WIRE)-- ZTE, one of the global leaders in the mobile handset manufacturing industry, launches its three new smartphone devices at this year’s Gitex Shopper and has announced its strategic partnership with Global Distribution FZE, a leading distributor of IT and Mobility products as the exclusive distributor of ZTE-Smartphone products in the UAE.

Aiming to take on a bigger market share in the Middle East smartphone market, ZTE is showcasing its flagship products – Grand SII LTE, Nubia Z5S Mini and Blade Vec 4G – to the region for the first time. Deemed to be a ‘game changer’ in the region’s smartphone segment, the launch of these products is part of the global telecommunications company’s strategic effort ... Read more »

Abu Dhabi, United Arab Emirates - Sunday, September 28th 2014 [ME NewsWire]

The Ministry of Interior showcased its child protection efforts during an international conference that recently concluded in Japan.

The Ministry of Interior’s experiences in the field of child protection were highly acclaimed by the attendees. Several delegations expressed their intention to enhance cooperation with the ministry and to get an overview of the latest developments in the UAE. These statements were made during a number of side meetings with the delegations of the United States, Canada, Australia, and the conference’s organizers.

The Ministry of Interior’s delegation took part in the XXth ISPCAN International Congress (International Society for the Prevention of Child Abuse and Neglect) that was held in the Japanese city of Nagoya from 14 to 17 September, under the theme “Towards child-centered societies: Learn from the past, act for the future&rdq ... Read more »

LONDON - Sunday, September 28th 2014 [ME NewsWire]

IMPRESS Study Results also Presented at the ESMO 2014 Congress Provide Increased Understanding of Treatment Options for Patients with EGFR Mutation Positive Advanced Non-Small Cell Lung Cancer who have Developed Acquired Resistance to First Line IRESSA

LONDON--(BUSINESS WIRE)-- Updated data from the ongoing AURA study of AZD9291 shows encouraging, although still immature, median progression free survival of 9.6 months (95% CI 8.3 to NC) in patients with epidermal growth factor receptor mutation positive (EGFRm) T790M+ advanced non-small cell lung cancer (NSCLC) who had disease progression following treatment with an EGFR tyrosine kinase inhibitor (EGFR TKI).1 The progression free survival (PFS) results are based on a 30% data maturity from 138 patients.1

Data presented at the European Society for Medical Oncology (ESMO) 2014 Congress support and strengthen the results highlighted earlier this year at the Amer ... Read more »

ME NewsWire/Business Wire

SUMMIT, N.J. - Saturday, September 27th 2014

In phase III studies, OTEZLA resulted in significant and clinically meaningful improvements in plaque psoriasis

OTEZLA demonstrated a consistent safety and tolerability profile across clinical trials

Celgene Corporation (NASDAQ: CELG) today announced that the U.S. Food and Drug Administration (FDA) has approved OTEZLA® (apremilast), the Company’s oral, selective inhibitor of phosphodiesterase 4 (PDE4), for the treatment of patients with moderate to severe plaque psoriasis for whom phototherapy or systemic therapy is appropriate. OTEZLA is the first and only PDE4 inhibitor approved for the treatment of plaque psoriasis. Psoriasis, a chronic inflammatory disease of the skin resulting from an uncontrolled immune response, affects more than 125 million people worldwide.

“OTEZLA offers an important new treatment option for patients whose symptoms are not adequate ... Read more »